Codiak BioSciences Inc. (CDAK) Social Stream

Featured Post From StockTwits About CDAK

$CDAK New SEC Filing: 8-K Earnings - Codiak BioSciences, Inc. (0001659352) August 05


Item 2.02—Results of Operations and Financial Condition On August 5, 2021, Codiak BioSciences, Inc. (the "Company") issued a press release announcing its financial results for the fiscal quarter ended June 30, 2021. The release also provided updated timing for announcement of data from the initial dose escalation cohorts in the Phase 1/2 trial of exoSTING. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. The information furnished under this Item 2.02 and in the accompanying Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act" (...)

https://mkn.re/89859